Kamada earnings were $22.3M for the trailing 12 months ending Jun 30, 2026, with 11.8% growth year over year. The latest KMDA earnings report on Jun 30, 2026 announced Q2 2026 earnings of $9.3M, up 124.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, KMDA reported annual earnings of $20.2M, with 39.7% growth.
KMDA past earnings growth
How has KMDA's earnings growth performed historically?
On KMDA's earnings call on Aug 12, 2026, Kamada (NASDAQ: KMDA) reported Q2 2026 earnings per share (EPS) of $0.16, up 23.08% year over year. Total KMDA earnings for the quarter were $9.26 million. In the same quarter last year, Kamada's earnings per share (EPS) was $0.13.
As of the last Kamada earnings report, Kamada is currently profitable. Kamada's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $22.25 million, a 17.05% increase year over year.
What was KMDA's earnings growth in the past year?
As of Kamada's earnings date in Aug 12, 2026, Kamada's earnings has grown 11.76% year over year. This is 91.6 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 103.37%. KMDA earnings in the past year totalled $22.25 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.